Bextra Withdrawn From Market
[Source: Medscape Headlines http://www.medscape.com/ ]
In addition, the FDA is requiring that all NSAID product labels include stronger warnings on cardiovascular and gastrointestinal adverse events...
permalink: comments: feedURL:http://www.medscape.com/cx/rssfeeds/general.xml
Pretty soon we will not have any NSAIDs with any reasonable GI protective effects. Fortunately, Celebrex is still on the market. There are some older NSAIDs with partial COX-2 selectivity, like etodolac and meloxicam, that many physicians will start depending on.
In addition, the FDA is requiring that all NSAID product labels include stronger warnings on cardiovascular and gastrointestinal adverse events...
permalink: comments: feedURL:http://www.medscape.com/cx/rssfeeds/general.xml
Pretty soon we will not have any NSAIDs with any reasonable GI protective effects. Fortunately, Celebrex is still on the market. There are some older NSAIDs with partial COX-2 selectivity, like etodolac and meloxicam, that many physicians will start depending on.
Quick Links
Calendar
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
Categories
Archives
Links
My .Mac Page
Private Area
Latinopundit
MacMinute
MacNetJournal
MacNN
Macsurfer
Mac OS X Hints
MedLogs
Medscape
Reuters Health
Slashdot
XML/RSS Feed
Syndicate this site
Search
|
|
Comments powered by
Statistics
Total entries in this blog:
Total entries in this category: 135
Published On: Apr 12, 2005 09:29 AM
Total entries in this category: 135
Published On: Apr 12, 2005 09:29 AM